<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-10T20:20:10+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2703】「2020金研奖」消化道肿瘤单元入围名单揭晓</title>
    <updated>2021-01-10T18:43:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/US0PkfB9znMP2DhiBVexjg</id>
    <link href="https://mp.weixin.qq.com/s/US0PkfB9znMP2DhiBVexjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>学术风暴启新程，「2020 GIST 年终盘点」主会场学术精粹报道</title>
    <updated>2021-01-10T18:43:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/POMG1sK6OXsICiYtQpfmZQ</id>
    <link href="https://mp.weixin.qq.com/s/POMG1sK6OXsICiYtQpfmZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>领袖汇聚倒计时丨中国肿瘤医药营销趋势论坛—医学分论坛</title>
    <updated>2021-01-10T18:43:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/48PCNu-1zMj9D36sFCWGGg</id>
    <link href="https://mp.weixin.qq.com/s/48PCNu-1zMj9D36sFCWGGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>权威数据｜超过肺癌，女性乳腺癌已成为全球最常见癌症</title>
    <updated>2021-01-10T18:43:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/SLVgkhLevi-pb6VwTOSEpg</id>
    <link href="https://mp.weixin.qq.com/s/SLVgkhLevi-pb6VwTOSEpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MDM2或HDM2抑制剂可为视网膜母细胞瘤患者提供治疗新选择</title>
    <updated>2021-01-10T18:43:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/G7UUAnTWxKcYR_CbMZPmxQ</id>
    <link href="https://mp.weixin.qq.com/s/G7UUAnTWxKcYR_CbMZPmxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>韩宝惠教授：生物类似药是未来主战场之一，安可达上市后疗效和安全性迅速获临床广泛认可</title>
    <updated>2021-01-09T20:02:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/SyxgbQq2wZ7PT4xk3zCi8g</id>
    <link href="https://mp.weixin.qq.com/s/SyxgbQq2wZ7PT4xk3zCi8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>孟志强教授：T+A肝癌免疫联合疗法中国上市，获益不止步于晚期患者</title>
    <updated>2021-01-09T20:02:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/rkiHS-KD1bKwcimAw_XUFA</id>
    <link href="https://mp.weixin.qq.com/s/rkiHS-KD1bKwcimAw_XUFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】转移性肾非透明细胞癌的治疗进展</title>
    <updated>2021-01-09T20:02:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/LoSjy98QaMtGGh6OTdwUqA</id>
    <link href="https://mp.weixin.qq.com/s/LoSjy98QaMtGGh6OTdwUqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【寒潮之下，灼热开启】1月10日！“精准强效，多维获益”——2021骨健康论坛暨安加维SRE上市会强势来袭！</title>
    <updated>2021-01-09T20:02:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/e5WNuQAbcIuqN2hE9J1kIg</id>
    <link href="https://mp.weixin.qq.com/s/e5WNuQAbcIuqN2hE9J1kIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时1天】2021北京泌尿肿瘤青年论坛暨泌尿肿瘤年终盘点——年度盛会，不容错过！</title>
    <updated>2021-01-09T20:02:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/4uSn0Yyg-qInQal7GqGDiA</id>
    <link href="https://mp.weixin.qq.com/s/4uSn0Yyg-qInQal7GqGDiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2701】【2020 SABCS】群英荟：DS-8201风头无两，或将重构抗HER2治疗新格局</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/LJrJLvABOQ9SqawLqgTp1w</id>
    <link href="https://mp.weixin.qq.com/s/LJrJLvABOQ9SqawLqgTp1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度巨制丨「骨与软组织肿瘤药物盘点」SESSION 1：骨肉瘤围手术期化疗</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/m7pL5uLECJ2wFFd0gEF2bQ</id>
    <link href="https://mp.weixin.qq.com/s/m7pL5uLECJ2wFFd0gEF2bQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】2020 SABCS|基于PALOMA-2和RWS，哌柏西利对ET越敏感获益越大，基础疾病/高龄不影响获益</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/QtIsNFpiL3qfd4AneoZEYg</id>
    <link href="https://mp.weixin.qq.com/s/QtIsNFpiL3qfd4AneoZEYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赵军教授：在NSCLC中，抗血管生成药物不可替代，安可达应用前景广阔</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/OauJ12_ItXYSxJdeBCLkLQ</id>
    <link href="https://mp.weixin.qq.com/s/OauJ12_ItXYSxJdeBCLkLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《肿瘤新视角》第一期：国际知名杂志的最新研究结果解读</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Og85M9MkhTJRqOKbq8yqMw</id>
    <link href="https://mp.weixin.qq.com/s/Og85M9MkhTJRqOKbq8yqMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“G辞典” | 了解GIST的抑制开关</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/J34CosrHSk0j-YbuGG94pg</id>
    <link href="https://mp.weixin.qq.com/s/J34CosrHSk0j-YbuGG94pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离就是战斗，有问必有所得” | 【1】诺雷得的使用秘籍在此！</title>
    <updated>2021-01-08T19:47:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/f3TxkaKRZPjhuoURgIX0wQ</id>
    <link href="https://mp.weixin.qq.com/s/f3TxkaKRZPjhuoURgIX0wQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2700】“买4个疗程保终身”，医保之外，慈善赠药惠及更多肿瘤患者</title>
    <updated>2021-01-07T19:52:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Zg2_HRdHZo1ocfdLMvTGKg</id>
    <link href="https://mp.weixin.qq.com/s/Zg2_HRdHZo1ocfdLMvTGKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人物专访 | 贝达药业万江：成功的肿瘤药营销重在患者可及，最终塑成品牌、商业双赢</title>
    <updated>2021-01-07T19:52:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Wl6kbglQWHeJKo1EoJp6Rw</id>
    <link href="https://mp.weixin.qq.com/s/Wl6kbglQWHeJKo1EoJp6Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>唐平章&amp;秦建武教授：安罗替尼获批上市，开启中国晚期甲状腺髓样癌靶向治疗新时代，填补治疗领域的空白、带来生存上的新高度</title>
    <updated>2021-01-07T19:52:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/vDue3syNg50Vm8A9Aq1IGQ</id>
    <link href="https://mp.weixin.qq.com/s/vDue3syNg50Vm8A9Aq1IGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>